{"id":"W1985877931","doi":"10.1016/j.ijrobp.2014.05.053","title":"Quality of Life in a Prospective, Multicenter Phase 2 Trial of Neoadjuvant Full-Dose Gemcitabine, Oxaliplatin, and Radiation in Patients With Resectable or Borderline Resectable Pancreatic Adenocarcinoma","year":2014,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Gemcitabine; Quality of life (healthcare); Oxaliplatin; Neoadjuvant therapy; Pancreatic cancer; Regimen; Radiation therapy; Internal medicine; Oncology; Cancer; Surgery; Colorectal cancer; Nursing; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002711361,0.001530022,0.002145542,0.0003289083,0.0005783078,0.001328936,0.0008030981,0.001058508,0.002640357],"category_scores_gemma":[0.001838002,0.0007482857,0.002456127,0.0005262609,0.001606071,0.001371717,0.0006562849,0.003591838,0.0004249194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001195081,"about_ca_system_score_gemma":0.001418763,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009734148,"about_ca_topic_score_gemma":0.002161576,"domain_scores_codex":[0.9989823,0.0006235694,0.00005765004,0.0001559172,0.00005307993,0.0001275188],"domain_scores_gemma":[0.998591,0.0003402521,0.000297484,0.0001330304,0.00005933185,0.0005789779],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9537399,0.01843394,0.008801006,0.0001629218,0.001280889,0.00004286278,0.0001416149,0.001088498,0.003257388,0.00006109041,0.0005950781,0.01239479],"study_design_scores_gemma":[0.6222852,0.3420001,0.03087913,0.00003036361,0.001495053,0.0001006771,0.0001458905,0.001341649,0.0007751886,0.0002238301,0.0006799265,0.00004292222],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983408,0.0005508767,0.0000952874,0.0002423749,0.00006446842,0.0002060303,0.0001817175,0.00001045059,0.0003078316],"genre_scores_gemma":[0.9971214,0.0004380824,0.0003598279,0.0003682977,0.00009869858,0.0005659316,0.0006281856,0.000008905918,0.0004107314],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002711361,"threshold_uncertainty_score":0.01433921,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02920745441167761,"score_gpt":0.373863098349797,"score_spread":0.3446556439381194,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}